Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 2Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1295Pancreatic Neoplasms 819Carcinoma, Hepatocellular 782Stomach Neoplasms 754Rectal Neoplasms 565Esophageal Neoplasms 452Colonic Neoplasms 414Esophageal Squamous Cell Carcinoma 277Neoplasm Metastasis 263Cholangiocarcinoma 251Liver Neoplasms 219Neoplasms 200Biliary Tract Neoplasms 179Adenocarcinoma Of Esophagus 139Gastrointestinal Stromal Tumors 108Gallbladder Neoplasms 96Adenocarcinoma 94Breast Neoplasms 91Gastrointestinal Neoplasms 89Carcinoma, Non-Small-Cell Lung 87Bile Duct Neoplasms 69Sarcoma 67Lung Neoplasms 64Ovarian Neoplasms 60Anus Neoplasms 59Melanoma 54Uterine Cervical Neoplasms 52Carcinoma 48Digestive System Neoplasms 45Prostatic Neoplasms 40

Interventions

atezolizumab 1Metformin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Fatty Liver × Gastrointestinal × Clear all
NCT06096779 2026-06-01

Kirros

Genentech, Inc.

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01523639 2018-12-19

G-LUCAS

Austrian Breast & Colorectal Cancer Study Group

Phase 2 Terminated
8 enrolled
Gastrointestinal

Fatty Liver, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡